Automated ICD Coding of Primary Diagnosis Based on Machine Learning

Sponsor
China National Center for Cardiovascular Diseases (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04817423
Collaborator
(none)
74,880
1
1
73521.3

Study Details

Study Description

Brief Summary

This study aims to develop and validate machine learning model in ICD-10 coding of primary diagnosis related to cardiovascular diseases in Chinese corpus.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

The accuracy and productivity of ICD coding has always been a concern of clinical practice. Errors of ICD codes may result in claim denials and missed revenue. However, ICD coding process is complex, time-consuming and error-prone. More experienced coders are in need, but there is an increasing lack of supply. Automated ICD coding has potential to facilitate clinical coders for improved efficiency and quality. Model performance of related studies is still far below coders and both the accuracy and interpretability need to be improved in great demand. Besides, studies in Chinese corpus are not sufficient.

In this study, the investigators will implement automated ICD coding study based on inpatient' data collected from electronic medical records from Fuwai Hospital, the world's largest medical center for cardiovascular disease. Feature engineering and machine learning methods will be used to develop classification models with good performance, interpretability and practicability for ICD codes of primary diagnosis.

Study Design

Study Type:
Observational
Anticipated Enrollment :
74880 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Automated ICD Coding of Primary Diagnosis Based on Machine Learning
Actual Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Apr 1, 2021
Anticipated Study Completion Date :
Apr 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Model training and test group

Data set will be split into training group and test group, where training group will be used for model building, and test group for subsequent evaluation and verification.

Other: No intervention
No intervention

Outcome Measures

Primary Outcome Measures

  1. ICD code of primary diagnosis [At the end of enrollment]

    Each admission will be a sample in this study. The ICD code of primary diagnosis assigned by medical coders for each admission will be collected as the primary outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Admissions in Fuwai Hospital, from January 1, 2019, to December 31, 2020
Exclusion Criteria:
  • Admissions stayed in nephrology department, Fuwai Hospital

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fuwai Hospital Beijing China

Sponsors and Collaborators

  • China National Center for Cardiovascular Diseases

Investigators

  • Principal Investigator: Wei Zhao, PhD, China National Center for Cardiovascular Diseases

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
China National Center for Cardiovascular Diseases
ClinicalTrials.gov Identifier:
NCT04817423
Other Study ID Numbers:
  • 2021-1425
First Posted:
Mar 26, 2021
Last Update Posted:
Mar 26, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 26, 2021